DocGo Inc.
DCGO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $71 | $80 | $96 | $121 |
| % Growth | -11.9% | -16.3% | -20.5% | – |
| Cost of Goods Sold | $53 | $55 | $65 | $80 |
| Gross Profit | $18 | $25 | $31 | $40 |
| % Margin | 25.6% | 31.6% | 32.1% | 33.5% |
| R&D Expenses | $3 | $3 | $4 | $4 |
| G&A Expenses | $36 | $36 | $37 | $41 |
| SG&A Expenses | $36 | $36 | $37 | $41 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $21 | $4 | $4 | $3 |
| Operating Expenses | $60 | $43 | $45 | $48 |
| Operating Income | -$42 | -$17 | -$14 | -$7 |
| % Margin | -59.3% | -21.7% | -14.6% | -6.2% |
| Other Income/Exp. Net | -$1 | -$0 | -$1 | $1 |
| Pre-Tax Income | -$43 | -$18 | -$15 | -$7 |
| Tax Expense | -$14 | -$5 | -$4 | $1 |
| Net Income | -$28 | -$11 | -$9 | -$3 |
| % Margin | -39.2% | -13.9% | -9.8% | -2.7% |
| EPS | -0.28 | -0.11 | -0.093 | -0.032 |
| % Growth | -154.5% | -18.8% | -189.4% | – |
| EPS Diluted | -0.28 | -0.11 | -0.093 | -0.032 |
| Weighted Avg Shares Out | 100 | 99 | 102 | 102 |
| Weighted Avg Shares Out Dil | 116 | 99 | 102 | 102 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $1 |
| Depreciation & Amortization | $4 | $4 | $4 | $3 |
| EBITDA | -$21 | -$13 | -$11 | -$3 |
| % Margin | -30% | -16.8% | -11.1% | -2.6% |